Extracellular Matrix and Cytokines: A Functional Unit

The extracellular matrix (ECM) as well as soluble mediators like cytokines can influence the behavior of cells in very distinct as well as cooperative ways. One group of ECM molecules which shows an especially broad cooperativety with cytokines and growth factors are the proteoglycans. Proteoglycans can interact with their core proteins as well as their glycosaminoglycan chains with cytokines. These interactions can modify the binding of cytokines to their cell surface receptors or they can lead to the storage of the soluble factors in the matrix. Proteoglycans themselves may even have cytokine activity. In this review we describe different proteoglycans and their interactions and relationships with cytokines and we discuss in more detail the extracellular regulation of the activity of transforming growth factor-β (TGF-β) by proteoglycans and other ECM molecules. In the third part the interaction of heparan sulfate chains with fibroblast growth factor-2 (FGF-2, basic FGF) as a prototype example for the interaction of heparin-binding cytokines with heparan sulfate proteoglycans is presented to illustrate the different levels of mutual dependence of the cytokine network and the ECM.

[1]  G. Yancopoulos,et al.  An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. , 1997, Molecular cell.

[2]  E. Schönherr,et al.  Expression of Small Extracellular Chondroitin/Dermatan Sulfate Proteoglycans Is Differentially Regulated in Human Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[3]  E. Schönherr,et al.  Selective inactivity of TGF‐β/decorin complexes , 1994 .

[4]  M. Goldfarb,et al.  Heparin can activate a receptor tyrosine kinase. , 1995, The EMBO journal.

[5]  Renato V. Iozzo,et al.  Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.

[6]  R. Friesel,et al.  Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  A. Chait,et al.  Human Monocyte-derived Macrophages Secrete Two Forms of Proteoglycan-Macrophage Colony-stimulating Factor That Differ in Their Ability to Bind Low Density Lipoproteins* , 1998, The Journal of Biological Chemistry.

[8]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[9]  E. Schönherr,et al.  Receptor-mediated endocytosis of decorin: involvement of leucine-rich repeat structures. , 1998, Archives of biochemistry and biophysics.

[10]  G. Boivin,et al.  TGF β 2 knockout mice have multiple developmental defects that are non-overlapping with other TGF β knockout phenotypes , 1997 .

[11]  E. Ruoslahti,et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.

[12]  D. Carey,et al.  Syndecans: multifunctional cell-surface co-receptors. , 1997, The Biochemical journal.

[13]  P. Klint,et al.  Signal transduction by fibroblast growth factor receptors. , 1999, Frontiers in bioscience : a journal and virtual library.

[14]  R. Juliano,et al.  Integrin-mediated signaling events in human endothelial cells. , 1998, Molecular biology of the cell.

[15]  J. Massagué,et al.  Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites , 1994, The Journal of cell biology.

[16]  A. Bikfalvi,et al.  The role of fibroblast growth factor-2 (FGF-2) in hematopoiesis. , 1995, Progress in growth factor research.

[17]  S. Sprang,et al.  Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Shimamura,et al.  Identification of binding domains for basic fibroblast growth factor in proteoglycan macrophage colony-stimulating factor. , 1997, Biochemical and biophysical research communications.

[19]  H Kresse,et al.  Interaction of Biglycan with Type I Collagen (*) , 1995, The Journal of Biological Chemistry.

[20]  Y. Kaneda,et al.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.

[21]  T Matsumoto,et al.  Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.

[22]  K. Stecker,et al.  [12] Role of transforming growth factor β and decorin in controlling fibrosis , 1994 .

[23]  J. Turnbull,et al.  Structural comparison of fibroblast growth factor-specific heparan sulfates derived from a growing or differentiating neuroepithelial cell line. , 1998, Glycobiology.

[24]  J. Massagué,et al.  Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system , 1991, Cell.

[25]  D. Rifkin,et al.  Latent transforming growth factor-beta: structural features and mechanisms of activation. , 1997, Kidney international.

[26]  H. Kresse,et al.  Endocytosis of a small dermatan sulphate proteoglycan. Identification of binding proteins. , 1989, The Biochemical journal.

[27]  L M Wakefield,et al.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Saraste,et al.  FEBS Lett , 2000 .

[29]  L. Rosenberg,et al.  Interaction of heparin cofactor II with biglycan and decorin. , 1993, The Journal of biological chemistry.

[30]  J. Massagué,et al.  TGF- SIGNAL TRANSDUCTION , 1998 .

[31]  J. Turnbull,et al.  Heparan sulphate: functional role as a modulator of fibroblast growth factor activity. , 1993, Biochemical Society transactions.

[32]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[33]  H. Kresse,et al.  Binding of heparin and of the small proteoglycan decorin to the same endocytosis receptor proteins leads to different metabolic consequences , 1991, The Journal of cell biology.

[34]  Nobuyuki Itoh,et al.  Structure and Expression of the mRNA Encoding a Novel Fibroblast Growth Factor, FGF-18* , 1998, The Journal of Biological Chemistry.

[35]  R. Derynck,et al.  Transforming growth factor‐α , 1990, Molecular reproduction and development.

[36]  J. Weiler,et al.  Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides. , 1997, Archives of biochemistry and biophysics.

[37]  N. Nagata,et al.  A proteoglycan form of macrophage colony-stimulating factor that binds to bone-derived collagens and can be extracted from bone matrix. , 1993, Biochemical and biophysical research communications.

[38]  U Lindahl,et al.  Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. , 1994, The Journal of biological chemistry.

[39]  F. Reinholt,et al.  Fibromodulin-null Mice Have Abnormal Collagen Fibrils, Tissue Organization, and Altered Lumican Deposition in Tendon* , 1999, The Journal of Biological Chemistry.

[40]  E. Ruoslahti,et al.  αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF , 1997 .

[41]  R. Iozzo,et al.  The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. , 1997, Critical reviews in biochemistry and molecular biology.

[42]  Y. Okada,et al.  Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. , 1997, The Biochemical journal.

[43]  M. Sporn,et al.  Transforming growth factor-beta: recent progress and new challenges , 1992, The Journal of cell biology.

[44]  F. Takaku,et al.  Identification of a high molecular weight macrophage colony-stimulating factor as a glycosaminoglycan-containing species. , 1992, The Journal of biological chemistry.

[45]  K. Schwarz,et al.  Proteoglycan form of colony-stimulating factor-1 (proteoglycan-100). Stimulation of activity by glycosaminoglycan removal and proteolytic processing. , 1995, Journal of immunology.

[46]  K. Miyazono,et al.  Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160. , 1997, The Biochemical journal.

[47]  Yaou Zhang,et al.  The G3 Domain of Versican Enhances Cell Proliferation via Epidermial Growth Factor-like Motifs* , 1998, The Journal of Biological Chemistry.

[48]  K. Schwarz,et al.  Biosynthesis and properties of a further member of the small chondroitin/dermatan sulfate proteoglycan family. , 1990, The Journal of biological chemistry.

[49]  A. Kulkarni,et al.  Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. , 1995, The American journal of pathology.

[50]  E. Kovacs,et al.  Fibrogenic cytokines and connective tissue production , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  D C Rees,et al.  Heparin Structure and Interactions with Basic Fibroblast Growth Factor , 1996, Science.

[52]  J. Prince,et al.  The primary structure of NG2, a novel membrane-spanning proteoglycan , 1991, The Journal of cell biology.

[53]  Terry Magnuson,et al.  Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican , 1998, The Journal of cell biology.

[54]  J. Turnbull,et al.  Structural Modification of Fibroblast Growth Factor-binding Heparan Sulfate at a Determinative Stage of Neural Development* , 1998, The Journal of Biological Chemistry.

[55]  J. Massagué,et al.  Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. , 1992, The Journal of biological chemistry.

[56]  T. Shinomura,et al.  Leucine-rich repeat glycoproteins of the extracellular matrix. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[57]  B. Olwin,et al.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.

[58]  M. Salmivirta,et al.  Heparan sulfate : a piece of information , 2004 .

[59]  J. Dichgans,et al.  Decorin gene transfer-mediated suppression of TGF-β synthesis abrogates experimental malignant glioma growth in vivo , 1998, Gene Therapy.

[60]  S. Goldstein,et al.  Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice , 1998, Nature Genetics.

[61]  B. Olwin,et al.  Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. , 1993, The Journal of biological chemistry.

[62]  J. Xu,et al.  An essential heparin-binding domain in the fibroblast growth factor receptor kinase. , 1993, Science.

[63]  D. Fernig,et al.  Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. , 1994, Progress in growth factor research.

[64]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[65]  E. Ruoslahti,et al.  Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. , 1990, The Journal of clinical investigation.

[66]  R. Iozzo.  Perlecan: a gem of a proteoglycan. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[67]  A. Zinsmeister,et al.  Modulation of collagen gene expression by cytokines: stimulatory effect of transforming growth factor-beta1, with divergent effects of epidermal growth factor and tumor necrosis factor-alpha on collagen type I and collagen type IV. , 1997, The Journal of laboratory and clinical medicine.

[68]  S. Fujiwara,et al.  Dermatopontin interacts with transforming growth factor beta and enhances its biological activity. , 1999, The Biochemical journal.

[69]  E. Stanley,et al.  The predominant form of secreted colony stimulating factor-1 is a proteoglycan. , 1992, The Journal of biological chemistry.

[70]  G. Boivin,et al.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.

[71]  A. Wetterwald,et al.  Synthesis of membrane‐ and matrix‐bound colony‐stimulating factor‐1 by cultured osteoblasts , 1996, Journal of cellular physiology.

[72]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[73]  E. Ruoslahti,et al.  Betaglycan has multiple binding sites for transforming growth factor-beta 1. , 1996, The Biochemical journal.

[74]  R. Iozzo.  Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.

[75]  R. Iozzo,et al.  Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. , 1998, The Journal of clinical investigation.

[76]  E. Ruoslahti,et al.  Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation , 1988, Nature.

[77]  T. Hunter,et al.  Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase , 1994, Nature.

[78]  T. Ochiya,et al.  PDGF α-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG 2 knockout mouse , 1999 .

[79]  A. Schmidtchen,et al.  Recycling of a glycosylphosphatidylinositol-anchored heparan sulphate proteoglycan (glypican) in skin fibroblasts. , 1995, Glycobiology.

[80]  E. Ruoslahti,et al.  The Proteoglycan Lectin Domain Binds Sulfated Cell Surface Glycolipids and Promotes Cell Adhesion* , 1999, The Journal of Biological Chemistry.

[81]  T Ochiya,et al.  PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse. , 1999, Journal of cell science.

[82]  E. Ruoslahti,et al.  Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans. , 1993, The Journal of biological chemistry.

[83]  J. Massagué,et al.  Betaglycan presents ligand to the TGFβ signaling receptor , 1993, Cell.

[84]  N. Kaminski,et al.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[85]  T. Hardingham,et al.  Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[86]  A. Kulkarni,et al.  Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. , 1995, Development.

[87]  E Ruoslahti,et al.  Integrins and anoikis. , 1997, Current opinion in cell biology.

[88]  V. Nurcombe,et al.  Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. , 1993, Science.

[89]  G. Boivin,et al.  Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. , 1995, The American journal of pathology.

[90]  J. Massagué,et al.  Binding of two growth factor families to separate domains of the proteoglycan betaglycan. , 1992, The Journal of biological chemistry.

[91]  S. Sinha,et al.  Cellular and extracellular biology of the latent transforming growth factor-beta binding proteins. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[92]  E. Schönherr,et al.  Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. , 1998, Archives of biochemistry and biophysics.

[93]  S. Schultz-Cherry,et al.  The Activation Sequence of Thrombospondin-1 Interacts with the Latency-associated Peptide to Regulate Activation of Latent Transforming Growth Factor-β* , 1999, The Journal of Biological Chemistry.

[94]  H. Kresse,et al.  Influence of decorin on fibroblast adhesion to fibronectin. , 1991, European journal of cell biology.

[95]  L. Attisano,et al.  Role of Endoglin in Cellular Responses to Transforming Growth Factor-β , 1998, The Journal of Biological Chemistry.

[96]  M. Makishima,et al.  Biological activity of a proteoglycan form of macrophage colony-stimulating factor and its binding to type V collagen. , 1992, The Journal of biological chemistry.